PolyTherics appoints new Chairman

18-Jun-2010 - United Kingdom

PolyTherics Limited announced that Dr Ken Cunningham has been appointed Chairman. Dr Mike Hayes, the current Non-Executive Chairman, will continue as a Non-Executive Director.

Dr Cunningham has over 20 years’ experience in the pharmaceutical industry. He is currently Chief Executive Officer of SkyePharma, having joined the Company in 2006, initially as Chief Operating Officer. Previously, he was Chief Executive Officer of Arakis Ltd, Vice-President European Affairs at Alza Corporation and Vice-President Clinical Development at Sequus Inc. Prior to this he held a variety of clinical development and commercial strategy roles at GlaxoWellcome plc and, earlier in his career, was with Warner-Lambert. Dr Cunningham is a Non-Executive Director of Xention Ltd. He holds a medical degree from St Mary's, Imperial College, London University.

Other news from the department people

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance